Thorium dioxide (Thorotrast)

Cirrhosis of the liver - Thorium dioxide (Thorotrast) Factor

Last reviewed for CCPS 12 March 2008.

Preliminary questions [20513]

22401 there is some evidence that thorium dioxide (Thorotrast) may be a factor in the development or worsening of the condition under consideration.

36773 the veteran has received thorium dioxide (Thorotrast) at some time.

36779 — the veteran received thorium dioxide (Thorotrast) for an illness or injury which is identifiable.

20666 — the veteran has established the causal connection between thorium dioxide (Thorotrast) and VEA service for cirrhosis of the liver.

20669 the veteran received thorium dioxide (Thorotrast) for the identified illness or injury, before the clinical onset of cirrhosis of the liver.

20667 — the veteran has established the causal connection between thorium dioxide (Thorotrast) and VEA service for the clinical onset of cirrhosis of the liver.

20671 — the veteran has established the causal connection between thorium dioxide (Thorotrast) and operational service for the clinical onset of cirrhosis of the liver.

or

20672 — the veteran has established the causal connection between thorium dioxide (Thorotrast) and eligible service for the clinical onset of cirrhosis of the liver.

or

7334

the clinical onset of the condition under consideration occurred after the end of the veteran's last period of VEA service.

7335

the condition under consideration permanently worsened.

20670

the veteran received thorium dioxide (Thorotrast) for the identified illness or injury, before the clinical worsening of cirrhosis of the liver.

20668 — the veteran has established the causal connection between thorium dioxide (Thorotrast) and VEA service for the clinical worsening of cirrhosis of the liver.

20673 — the veteran has established the causal connection between thorium dioxide (Thorotrast) and operational service for the clinical worsening of cirrhosis of the liver.

or

20674 — the veteran has established the causal connection between thorium dioxide (Thorotrast) and eligible service for the clinical worsening of cirrhosis of the liver.

Clinical onset and operational service [20671]

36782 — the identified illness or injury, for which the veteran received thorium dioxide (Thorotrast), is causally related to operational service.

Clinical onset and eligible service [20672]

36783 — the identified illness or injury, for which the veteran received thorium dioxide (Thorotrast), is causally related to eligible service.

Clinical worsening and operational service [20673]

36782 — the identified illness or injury, for which the veteran received thorium dioxide (Thorotrast), is causally related to operational service.

22172

the clinical onset of cirrhosis of the liver occurred prior to that part of operational service to which the identified illness or injury, for which the veteran received thorium dioxide (Thorotrast), is causally related.

Clinical worsening and eligible service [20674]

36783 — the identified illness or injury, for which the veteran received thorium dioxide (Thorotrast), is causally related to eligible service.

22173

the clinical onset of cirrhosis of the liver occurred prior to that part of eligible service to which the identified illness or injury, for which the veteran received thorium dioxide (Thorotrast), is causally related.